ofloxacin has been researched along with Infectious Endophthalmitis in 53 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Infectious Endophthalmitis: Infectious condition of the internal eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether the foldable capsular vitreous body (FCVB) could release levofloxacin sustainably in vitro and inhibit endophthalmitis in rabbit models." | 7.79 | A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits. ( Feng, L; Gao, Q; Huang, X; Jiang, Z; Li, Y; Lin, J; Lin, X; Liu, Y; Wang, T; Xie, Z, 2013) |
| "5% levofloxacin versus combined treatment with vancomycin and ceftazidime in an experimental model of bacterial endophthalmitis." | 7.74 | Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis. ( Abad, JL; Alió, JL; Fernandez, J; Ferrer, C; Rodríguez, A, 2008) |
| "Endogenous endophthalmitis is a rare complication of infective endocarditis and has been decreasing due to the availability of effective antibiotics." | 5.35 | Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis. ( Dinani, A; Ktaich, N; Rubin, D; Urban, C, 2009) |
| "This partially masked randomized placebo-controlled multinational clinical study was designed to evaluate prospectively the prophylactic effect of intracameral cefuroxime and/or perioperative topical levofloxacin on postoperative endophthalmitis after cataract surgery." | 5.12 | ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. ( Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV; Wilhelmus, KR, 2006) |
| "This partially masked randomized placebo-controlled multinational clinical study to evaluate prospectively the prophylactic effect of intracameral cefuroxime injection and/or perioperative levofloxacin eyedrops on the incidence of endophthalmitis after phacoemulsification cataract surgery began in September 2003 and was terminated early in January 2006." | 5.12 | ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. ( Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV, 2006) |
| "Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis." | 5.12 | Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. ( , 2007) |
| "Ofloxacin has the best aqueous penetration in human eyes, as compared with ciprofloxacin and tobramycin, which suggests ofloxacin could be the preferred topical medicine for the prevention and treatment of endophthalmitis." | 5.10 | [Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin]. ( Wu, XD; Yang, YH; Yao, K; Zhang, Z, 2003) |
| " A MEDLINE search was conducted using the following search terms: moxifloxacin or gatifloxacin; levofloxacin; minimum inhibitory concentration or prevention or prophylaxis; keratitis or endophthalmitis." | 4.84 | Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. ( Scoper, SV, 2008) |
| "We investigated whether the foldable capsular vitreous body (FCVB) could release levofloxacin sustainably in vitro and inhibit endophthalmitis in rabbit models." | 3.79 | A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits. ( Feng, L; Gao, Q; Huang, X; Jiang, Z; Li, Y; Lin, J; Lin, X; Liu, Y; Wang, T; Xie, Z, 2013) |
| "Our protocol to achieve high aqueous humor concentrations of levofloxacin may be favorable in preventing endophthalmitis after eye surgery." | 3.77 | Efficient penetration into aqueous humor by administration of oral and topical levofloxacin. ( Ishida, M; Iwaki, M; Kataoka, T; Niwa, K; Zako, M, 2011) |
| " In open eye surgery, an additional antibioprophylaxis is recommended: in cataract surgery, injection in the anterior chamber at the end of the procedure of 1mg of cefuroxime; in other open eye surgeries, only in case of risk factors for endophthalmitis, administration of 500 mg oral levofloxacin tablet 12 hours and two hours before surgery." | 3.77 | [Antibioprophylaxis in ocular surgery: AFSSAPS recommendations]. ( Cochereau, I; Hajjar, J; Korobelnik, JF; Robert, PY, 2011) |
| "To investigate the safety of intracameral injection of gatifloxacin, levofloxacin in a rabbit model as prophylaxis against endophthalmitis." | 3.75 | Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability. ( Choi, JA; Chung, SK, 2009) |
| "5% levofloxacin versus combined treatment with vancomycin and ceftazidime in an experimental model of bacterial endophthalmitis." | 3.74 | Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis. ( Abad, JL; Alió, JL; Fernandez, J; Ferrer, C; Rodríguez, A, 2008) |
| "3% gatifloxacin ophthalmic solution in preventing bacterial endophthalmitis in rabbits." | 3.74 | Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits. ( Kozai, S; Ohashi, Y; Sakaki, H; Suzuki, T; Tajika, T; Wada, T, 2008) |
| "To determine the in vitro efficacy of levofloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae and Streptococcus viridans isolates recovered from clinical cases of keratitis and endophthalmitis." | 3.72 | Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates. ( Alfonso, EC; Miller, D, 2004) |
| "Vitreous levels of ofloxacin were above the MIC(90) at 2 and 8 h in all groups for most of the common microorganisms causing endophthalmitis and also at 24 h in traumatized-infected eyes." | 3.70 | Ofloxacin levels after intravitreal injection. Effects of trauma and inflammation. ( Basci, NE; Bozkurt, A; Kortunay, S; Kurt, E; Oguz Kayaalp, S; Oztürk, F; Sami Ilker, S; Ubeyt Inan, U, 1999) |
| "This study aimed to investigate the penetration of topical and oral ofloxacin into aqueous humor and vitreous humor in post-traumatic endophthalmitis model in rabbits." | 3.70 | Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes. ( Başci, NE; Bozkurt, A; Ilker, SS; Inan, UU; Kortunay, MC; Kurt, E; Oztürk, F, 2000) |
| "25 %) of povidone-iodine (PI) eye drops, combined with 0." | 2.77 | Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection. ( Gomi, F; Ikuno, Y; Maeda, N; Nishida, K; Sawa, M; Tsujikawa, M, 2012) |
| "Endogenous endophthalmitis is a rare complication of infective endocarditis and has been decreasing due to the availability of effective antibiotics." | 1.35 | Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis. ( Dinani, A; Ktaich, N; Rubin, D; Urban, C, 2009) |
| "Ofloxacin levels were determined in aqueous humor, vitreous humor, and serum by a bioassay." | 1.29 | Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits. ( Gatti, G; Panozzo, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.77) | 18.7374 |
| 1990's | 5 (9.43) | 18.2507 |
| 2000's | 35 (66.04) | 29.6817 |
| 2010's | 10 (18.87) | 24.3611 |
| 2020's | 1 (1.89) | 2.80 |
| Authors | Studies |
|---|---|
| Martin Hita, L | 1 |
| Casanovas Moreno-Torre, I | 1 |
| Molina Esteban, J | 1 |
| Foronda García-Hidalgo, C | 1 |
| Guillot Suay, V | 1 |
| Navarro Mari, JM | 1 |
| Plotas, P | 1 |
| Makri, OE | 1 |
| Georgalas, I | 1 |
| Pharmakakis, N | 1 |
| Vantarakis, A | 1 |
| Georgakopoulos, CD | 1 |
| Bashir, G | 1 |
| Hussain, W | 1 |
| Rizvi, A | 1 |
| Jensen, MK | 2 |
| Fiscella, RG | 2 |
| Moshirfar, M | 2 |
| Mooney, B | 2 |
| Scoper, SV | 1 |
| Tsuchiya, Y | 1 |
| Kobayakawa, S | 1 |
| Tsuji, A | 1 |
| Tochikubo, T | 1 |
| Lindstrom, RL | 1 |
| Holland, EJ | 1 |
| Lane, SS | 1 |
| McCulley, JP | 1 |
| Dinani, A | 1 |
| Ktaich, N | 1 |
| Urban, C | 1 |
| Rubin, D | 1 |
| Choi, JA | 1 |
| Chung, SK | 1 |
| George, JM | 1 |
| Fiscella, R | 1 |
| Blair, M | 1 |
| Rodvold, K | 1 |
| Ulanski, L | 1 |
| Stokes, J | 1 |
| Blair, N | 1 |
| Pontiggia, L | 1 |
| Ishida, M | 1 |
| Kataoka, T | 1 |
| Niwa, K | 1 |
| Iwaki, M | 1 |
| Zako, M | 1 |
| Cochereau, I | 1 |
| Korobelnik, JF | 1 |
| Robert, PY | 1 |
| Hajjar, J | 1 |
| Jiang, Z | 2 |
| Wang, P | 1 |
| Pan, B | 1 |
| Xie, Z | 2 |
| Li, D | 1 |
| Wang, T | 2 |
| Liu, Y | 2 |
| Yuan, Z | 1 |
| Gao, Q | 2 |
| Cernak, M | 1 |
| Majtanova, N | 1 |
| Cernak, A | 1 |
| Majtan, J | 1 |
| Ikuno, Y | 1 |
| Sawa, M | 1 |
| Tsujikawa, M | 1 |
| Gomi, F | 1 |
| Maeda, N | 1 |
| Nishida, K | 1 |
| Tasaka, Y | 1 |
| Suzuki, T | 2 |
| Kawasaki, S | 1 |
| Uda, T | 1 |
| Mito, T | 1 |
| Uno, T | 1 |
| Ohashi, Y | 2 |
| Huang, X | 1 |
| Feng, L | 1 |
| Li, Y | 1 |
| Lin, X | 1 |
| Lin, J | 1 |
| Kherani, F | 1 |
| Kherani, A | 1 |
| Gehrs, KM | 1 |
| Heilskov, TW | 1 |
| Sutphin, JE | 1 |
| Wagoner, MD | 1 |
| Yao, K | 1 |
| Zhang, Z | 1 |
| Yang, YH | 1 |
| Wu, XD | 1 |
| Miller, D | 1 |
| Alfonso, EC | 1 |
| Ferrer, C | 2 |
| Ruiz-Moreno, JM | 1 |
| Rodríguez, A | 2 |
| Montero, J | 1 |
| Alió, JL | 2 |
| Crandall, AS | 1 |
| Wallin, T | 1 |
| Olson, RJ | 1 |
| Pea, F | 1 |
| Ferrari, E | 1 |
| Pavan, F | 1 |
| Roman-Pognuz, D | 1 |
| Bandello, F | 1 |
| Furlanut, M | 1 |
| Barkana, Y | 1 |
| Almer, Z | 1 |
| Segal, O | 1 |
| Lazarovitch, Z | 1 |
| Avni, I | 1 |
| Zadok, D | 1 |
| Bloom, C | 1 |
| Thomson, EC | 1 |
| Main, J | 1 |
| Izdebska, J | 1 |
| Szaflik, JP | 1 |
| Freisberg, L | 1 |
| Starr, MB | 1 |
| Katz, HR | 1 |
| Seal, DV | 2 |
| Barry, P | 2 |
| Gettinby, G | 2 |
| Lees, F | 2 |
| Peterson, M | 2 |
| Revie, CW | 2 |
| Wilhelmus, KR | 1 |
| Yağci, R | 1 |
| Oflu, Y | 1 |
| Dinçel, A | 1 |
| Kaya, E | 1 |
| Yağci, S | 1 |
| Bayar, B | 1 |
| Duman, S | 2 |
| Bozkurt, A | 4 |
| Bohigian, GM | 1 |
| Colyer, MH | 1 |
| Weber, ED | 1 |
| Weichel, ED | 1 |
| Dick, JS | 1 |
| Bower, KS | 1 |
| Ward, TP | 1 |
| Haller, JA | 1 |
| Spokes, DM | 1 |
| Walters, G | 1 |
| Altiparmak, UE | 1 |
| Ozer, PA | 1 |
| Ozkuyumcu, C | 1 |
| Us, AD | 1 |
| Aslan, BS | 1 |
| Miño de Kaspar, H | 1 |
| Kreutzer, TC | 1 |
| Aguirre-Romo, I | 1 |
| Ta, CN | 1 |
| Dudichum, J | 1 |
| Bayrhof, M | 1 |
| Klauss, V | 1 |
| Kampik, A | 1 |
| Abad, JL | 1 |
| Fernandez, J | 1 |
| Wada, T | 1 |
| Kozai, S | 1 |
| Tajika, T | 1 |
| Sakaki, H | 1 |
| Sakai, H | 1 |
| Mochizuki, K | 1 |
| Torisaki, M | 1 |
| Yamashita, Y | 1 |
| Komatsu, M | 1 |
| Tanahashi, T | 1 |
| Gatti, G | 1 |
| Panozzo, G | 1 |
| Le Thi Huong, D | 1 |
| Cassoux, N | 1 |
| Kemali, Z | 1 |
| Wechsler, B | 1 |
| Blétry, O | 1 |
| Le Hoang, P | 1 |
| Piette, JC | 1 |
| Oztürk, F | 3 |
| Kortunay, S | 2 |
| Kurt, E | 3 |
| Ubeyt Inan, U | 1 |
| Sami Ilker, S | 1 |
| Basci, NE | 2 |
| Oguz Kayaalp, S | 1 |
| Inan, UU | 2 |
| Ilker, SS | 2 |
| Basci, N | 1 |
| Kortunay, MC | 1 |
| Tandon, A | 1 |
| Tay-Kearney, ML | 1 |
| Metcalf, C | 1 |
| McAllister, L | 1 |
| Mather, R | 1 |
| Karenchak, LM | 1 |
| Romanowski, EG | 1 |
| Kowalski, RP | 2 |
| Keverline, MR | 1 |
| Dhaliwal, DK | 1 |
| Fisch, A | 1 |
| Lafaix, C | 1 |
| Salvanet, A | 1 |
| Cherifi, M | 1 |
| Meulemans, A | 1 |
| Bron, A | 1 |
| Talon, D | 1 |
| Delbosc, B | 1 |
| Estavoyer, JM | 1 |
| Kaya, G | 1 |
| Royer, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intracameral Levofloxacin (0.5%) Versus Intracameral Cefuroxime (1mg/0.1ml) Effect on Corneal Endothelial Cell Count and Morphology in Uneventful Phacoemulsification[NCT04212078] | Phase 1/Phase 2 | 138 participants (Anticipated) | Interventional | 2019-07-29 | Recruiting | ||
| To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis (Pilot Study)[NCT02201186] | Phase 2 | 10 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| The Effects on Betadine 5% Penetration When Using Lidocaine 2% Jelly Versus Topical Tetracaine 0.5% for Topical Phacoemulsification Cataract Surgery.[NCT00827073] | 40 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| Antibiotic Prophylaxis for Cataract Surgery Version 7e January 22 2003[NCT00136344] | 35,000 participants | Interventional | 2003-09-30 | Completed | |||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial[NCT02770729] | Phase 3 | 3,640 participants (Actual) | Interventional | 2017-01-31 | Terminated | ||
| Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery[NCT00491049] | Phase 4 | 140 participants (Actual) | Interventional | 2004-09-30 | Completed | ||
| Concentration of Ofloxacin Into the Aqueous Humour of Patients After Topical Instillation According to the Severity of Dry Eye Disease[NCT05213156] | Phase 4 | 91 participants (Actual) | Interventional | 2019-09-24 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Within 3 hours from time of culture acquisition, the samples will be vortexed for 30 seconds and 100µl aliquots will be plated onto 5% sheep blood and chocolate agar plates. These plates will be incubated with 5% carbon dioxide at 35˚ C for 72 hours. After 72 hours all plates will be read for colony count and identification of all isolates will be performed using routine microbiological methods. The natural log of bacterial bacterial colony count will be used for the outcome measure. (NCT00827073)
Timeframe: (1) Pre-antibiotics swab, and (2) Post-study medication (pre surgery)
| Intervention | Ln(bacterial colony count) (Mean) |
|---|---|
| Tetracaine 0.5% Drop | -0.14 |
| Lidocaine 2% Jelly | -0.52 |
(NCT00827073)
Timeframe: (1) Pre-antibiotics swab and (2) Post-study medication (pre surgery)
| Intervention | bacterial spceies (Mean) | |
|---|---|---|
| pre number of bacterial spices | post surgery number of bacterial speices | |
| Lidocaine 2% Jelly | 1 | 1 |
| Tetracaine 0.5% Drop | 1 | 1 |
2 reviews available for ofloxacin and Infectious Endophthalmitis
| Article | Year |
|---|---|
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Endophthalmitis; Fluoroquinolones; Ga | 2008 |
[Levofloxacin (oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery--the study of the European Society of Cataract and Refractive Surgeons (ESCRS)].
Topics: Administration, Topical; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Europe; Humans; Injecti | 2005 |
10 trials available for ofloxacin and Infectious Endophthalmitis
| Article | Year |
|---|---|
Efficacy of Topical Ofloxacin 0.3 % Administration on Conjunctival Bacterial Flora in Diabetic Patients Undergoing Intravitreal Injections.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bacteria; Conjunctiva; Diabetic Retinop | 2017 |
Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Aqueous Humor; Drug Therapy, C | 2010 |
Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery.
Topics: Abies; Anti-Bacterial Agents; Cataract Extraction; Corynebacterium; Drug Evaluation; Endophthalmitis | 2012 |
Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection.
Topics: Angiogenesis Inhibitors; Anti-Infective Agents, Local; Antibodies, Monoclonal, Humanized; Bacteria; | 2012 |
[Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin].
Topics: Administration, Topical; Aged; Aqueous Humor; Ciprofloxacin; Endophthalmitis; Female; Humans; Male; | 2003 |
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Endophthalmitis; | 2005 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Bacteriologi | 2008 |
41 other studies available for ofloxacin and Infectious Endophthalmitis
| Article | Year |
|---|---|
Listeria monocytogenes, a rare cause of endophthalmitis.
Topics: Anti-Bacterial Agents; Endophthalmitis; Humans; Listeria monocytogenes; Listeriosis; Male; Microbial | 2020 |
Bipolaris hawaiiensis keratomycosis and endophthalmitis.
Topics: Agriculture; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Cornea; Corneal Injuries; Corneal | 2009 |
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprof | 2008 |
Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cataract E | 2008 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye In | 2009 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye In | 2009 |
Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis.
Topics: Aged; Aged, 80 and over; Drug Resistance, Bacterial; Echocardiography; Endocarditis, Subacute Bacter | 2009 |
Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.
Topics: Animals; Anterior Chamber; Anti-Infective Agents; Cell Survival; Endophthalmitis; Endothelium, Corne | 2009 |
Efficient penetration into aqueous humor by administration of oral and topical levofloxacin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Chromatog | 2011 |
[Antibioprophylaxis in ocular surgery: AFSSAPS recommendations].
Topics: Administration, Oral; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extr | 2011 |
[Antibioprophylaxis in ocular surgery. Recommendations].
Topics: Administration, Oral; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime | 2011 |
Evaluation of levofloxacin release characteristics from a human foldable capsular vitreous body in vitro.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Delayed-Action Preparations; Dose-Response Relationsh | 2012 |
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aphakia, Postcataract; Aza Compounds; Di | 2013 |
A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.
Topics: Animals; Anti-Bacterial Agents; Ciliary Body; Colony Count, Microbial; Cytokines; Drug Delivery Syst | 2013 |
Xanthomonas maltophilia endophthalmitis following penetrating corneal injury.
Topics: Amphotericin B; Cornea; Corneal Injuries; Drug Therapy, Combination; Endophthalmitis; Eye Infections | 2002 |
Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Endophthalmitis; Humans; Keratitis; Levofloxacin; Microbial Se | 2004 |
Postoperative Corynebacterium macginleyi endophthalmitis.
Topics: Aged; Aqueous Humor; Bacterial Typing Techniques; Cataract Extraction; Chronic Disease; Corynebacter | 2004 |
A retrospective study of endophtalmitis rates comparing quinolone antibiotics.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross | 2005 |
Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting.
Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacteria; Chlorhexidine; Colony Count, Microbi | 2005 |
An elderly lady with sudden blindness and a sore foot.
Topics: Administration, Topical; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blindness; Ceftriaxon | 2006 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bact | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bact | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bact | 2005 |
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; | 2007 |
ESCRS study of endophthalmitis prophylaxis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Combined Modality Therapy; Endophthalmitis; Eye Enuclea | 2007 |
Prophylaxis of postoperative endophthalmitis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2007 |
Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Bacillus cereus; Bacteri | 2007 |
Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Female; Levofloxacin; Male; Microbial | 2008 |
Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Biological Availability; Disease Progression; Endo | 2008 |
Nontoxic intravitreal dose of ofloxacin for rabbit retina.
Topics: Animals; Electroretinography; Endophthalmitis; Evoked Potentials, Visual; Injections; Ofloxacin; Rab | 1994 |
Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits.
Topics: Animals; Bacterial Infections; Endophthalmitis; Eye; Ofloxacin; Rabbits | 1995 |
[Endogenous infectious endophthalmitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Fl | 1998 |
Ofloxacin levels after intravitreal injection. Effects of trauma and inflammation.
Topics: Animals; Anti-Infective Agents; Endophthalmitis; Eye Injuries; Half-Life; Injections; Ofloxacin; Osm | 1999 |
The effect of long-term use and inflammation on the ocular penetration of topical ofloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Endophthalmitis; Eye; Eye In | 1999 |
Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Endophthalmitis; Female; Mal | 2000 |
Bacillus circulans endophthalmitis.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacillaceae Infections; Bacillus; Cephalosporins; Ce | 2001 |
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophtha | 2002 |
In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis.
Topics: Anti-Infective Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacteria; Ciprofloxacin | 2002 |
Ofloxacin in human aqueous humour and lens.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aqueous Humor; Endophthalmitis; Humans; Lens, | 1987 |
[Intracamera penetration of ofloxacin in man].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Endophthalmitis | 1987 |